166 related articles for article (PubMed ID: 25953029)
1. Modulating APOBEC expression enhances DNA vaccine immunogenicity.
Almeida RR; Raposo RA; Coirada FC; da Silva JR; de Souza Ferreira LC; Kalil J; Nixon DF; Cunha-Neto E
Immunol Cell Biol; 2015 Nov; 93(10):868-76. PubMed ID: 25953029
[TBL] [Abstract][Full Text] [Related]
2. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
3. Excessive activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide 2 (APOBEC2) contributes to liver and lung tumorigenesis.
Okuyama S; Marusawa H; Matsumoto T; Ueda Y; Matsumoto Y; Endo Y; Takai A; Chiba T
Int J Cancer; 2012 Mar; 130(6):1294-301. PubMed ID: 21469143
[TBL] [Abstract][Full Text] [Related]
4. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.
Chen Z; Eggerman TL; Patterson AP
Biochem J; 2001 Aug; 357(Pt 3):661-72. PubMed ID: 11463337
[TBL] [Abstract][Full Text] [Related]
6. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
[TBL] [Abstract][Full Text] [Related]
7. Zinc-binding domain-dependent, deaminase-independent actions of apolipoprotein B mRNA-editing enzyme, catalytic polypeptide 2 (Apobec2), mediate its effect on zebrafish retina regeneration.
Powell C; Cornblath E; Goldman D
J Biol Chem; 2014 Oct; 289(42):28924-41. PubMed ID: 25190811
[TBL] [Abstract][Full Text] [Related]
8. Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy.
Sato Y; Probst HC; Tatsumi R; Ikeuchi Y; Neuberger MS; Rada C
J Biol Chem; 2010 Mar; 285(10):7111-8. PubMed ID: 20022958
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
10. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
11. APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation.
Lorenzo JP; Molla L; Amro EM; Ibarra IL; Ruf S; Neber C; Gkougkousis C; Ridani J; Subramani PG; Boulais J; Harjanto D; Vonica A; Di Noia JM; Dieterich C; Zaugg JB; Papavasiliou FN
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2312330121. PubMed ID: 38625936
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B: from editosome to proteasome.
Chan L; Chang BH; Liao W; Oka K; Lau PP
Recent Prog Horm Res; 2000; 55():93-125; discussion 126. PubMed ID: 11036935
[TBL] [Abstract][Full Text] [Related]
13. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
14. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
Chester A; Scott J; Anant S; Navaratnam N
Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
[TBL] [Abstract][Full Text] [Related]
15. Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.
Blanc V; Henderson JO; Newberry EP; Kennedy S; Luo J; Davidson NO
Mol Cell Biol; 2005 Aug; 25(16):7260-9. PubMed ID: 16055734
[TBL] [Abstract][Full Text] [Related]
16. Apobec-1 and apolipoprotein B mRNA editing.
Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
[TBL] [Abstract][Full Text] [Related]
17. Novel strategies to improve DNA vaccine immunogenicity.
Coban C; Kobiyama K; Aoshi T; Takeshita F; Horii T; Akira S; Ishii KJ
Curr Gene Ther; 2011 Dec; 11(6):479-84. PubMed ID: 22023477
[TBL] [Abstract][Full Text] [Related]
18. Effects of apo E deficiency on plasma lipid levels in mice lacking APOBEC-1.
Osuga J; Yagyu H; Ohashi K; Harada K; Yazaki Y; Yamada N; Ishibashi S
Biochem Biophys Res Commun; 1997 Jul; 236(2):375-8. PubMed ID: 9240444
[TBL] [Abstract][Full Text] [Related]
19. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
Mukhopadhyay D; Plateroti M; Anant S; Nassir F; Samarut J; Davidson NO
Endocrinology; 2003 Feb; 144(2):711-9. PubMed ID: 12538634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
